 NEW YORK, March 10, 2021 GLOBE NEWSWIRE -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aquestive Therapeutics, Inc. NASDAQ: AQST between December 2, 2019 and September 25, 2020, inclusive the Class Period, of the important April 30, 2021 lead plaintiff deadline. 